iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Mars Medical acquires further stake in Shalby's Singapore arm; stock slips ~2%

25 Mar 2022 , 12:43 PM

Shalby Limited wholly-owned Subsidiary Mars Medical Devices Limited (MMDL) has further subscribed 3,50,000 equity shares of SGD 1 each in MMDL’S Subsidiary – Shalby Global Technologies Pte. Ltd., Singapore {SGTPL), and remitted funds for the same on March 24, 2022.

SGTPL is a subsidiary of Mars Medical Devices Limited and a Step-down Subsidiary of the Company. Shareholding of MMDL in SGTPL is now increased to 98.76% from 97.82%.

The company engages in wholesale of medical, professional, scientific, and precision equipment, the company said in the filing.

The cost of further acquisition is 3,50,000 SGD, and consequently, the company holds 7,99,000 shares in Shalby Global.

Shalby Ltd is currently trading at Rs124.95 down by Rs2.05 or 1.61% from its previous closing of Rs127 on the BSE. The scrip opened at Rs128 and has touched day’s high and low of Rs128.70 and Rs124.25 respectively.

Related Tags

  • acquisition
  • Shalby
  • ShalbyAcquisition
  • ShalbyNews
  • ShalbyStock
  • ShalbyUpdates
  • ShareAcquisition
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.